BRAC Bank PLC has launched the country’s first SME innovation lab, titled “Finnovision”, aimed at helping small businesses grow and thrive through the adoption of innovative solutions.

However, many women with BRCA mutations perceive MHT as unsafe, due to concerns about their already elevated breast cancer ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...

More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...

Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

RAD51-based assessment effectively identifies HER2-negative metastatic breast cancer patients likely to respond to olaparib, especially with BRCA1/2 or PALB2 variants. RAD51-low tumors showed a higher ...

Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has signed an agreement with ...